In addition, studies on mice with NAFLD have shown that GDF-15 may ameliorate hepatic steatosis and NASH through direct anti-steatotic and anti-inflammatory effects that may be independent of reduction in body weight [207]. This evidence concerns the gene GDF15 and Hepatic steatosis.